Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07836010 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Suzetrigine Added to Multimodal Analgesia for Women Undergoing Minimally Invasive Hysterectomy

Name: Suzetrigine Added to Multimodal Analgesia for Women Undergoing Minimally Invasive Hysterectomy — clinical trial record (NCT07836010)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 4

SponsorDuke University

Started2026-11

View on ClinicalTrials.gov ↗

Duke University

455 trials monitored

See 53 trials at risk

This study will assess the analgesic efficacy of suzetrigine as part of a multimodal analgesic regimen in women undergoing laparoscopic or robotic hysterectomy. Outcomes will be compared with matched historical controls receiving the current ERAS regimen without suzetrigine.

Trial Details

NCT Number	NCT07836010
Lead Sponsor	Duke University Collaborators: Vertex Pharmaceuticals Incorporated
Conditions	Postoperative Pain
Enrollment	123 participants
Start Date	2026-11
Primary Completion	2028-01 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-09-23